Preoperative Intravenous Omega 3 Fatty Acids Administration in Valvular Surgery Patients
Valvular Surgery · Inflammation
Enrolment: 40 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Valvular Surgery · Inflammation
Enrolment: 40 · Results not recorded
Malnutrition · Colorectal Cancer
Enrolment: 36 · Results not recorded
Diabetes Mellitus, Type 2 · Hypertriglycemia
Enrolment: 68 · Results not recorded
COVID-19
Enrolment: 372 · Results not recorded
Attention Deficit/Hyperactivity Disorder (ADHD)
Enrolment: 200 · Results not recorded
Severe Hypertriglyceridemia
Enrolment: 54 · Results not recorded
Healthy Volunteers
Enrolment: 75 · Results not recorded
Breast Cancer
Enrolment: 24 · Results not recorded
Heart Disease
Enrolment: 120 · Results not recorded
Omega-3 Fatty Acid Supplementation, Physical Fitness
Enrolment: 60 · Results not recorded
Diabetic Neuropathies
Enrolment: 31 · Results not recorded
Subconcussive Head Impact · Omega-3 Fatty Acids
Enrolment: 208 · Results not recorded
Muscle Weakness
Enrolment: 73 · Results not recorded
Obesity
Enrolment: 23 · Results not recorded
Muscle Damage
Enrolment: 2 · Results not recorded
Healthy
Enrolment: 600 · Results not recorded
Lupus Erythematosus, Systemic
Enrolment: 80 · Results not recorded
Keratoconjunctivitis Sicca
Enrolment: 62 · Results not recorded
Prostate Cancer
Enrolment: 37 · Results not recorded
2 studies reported at therapy level; 2 evidence entries itemised.
Model: Acute cardiorenal toxicity induced by a single intraperitoneal injection of doxorubicin 200 mg/kg, with assessment 48 h later
Doxorubicin raised serum creatine kinase about 2.4-fold and urea and creatinine 2-fold and 2.6-fold. Omega-3 at 25, 50 and 100 mg/kg suppressed creatine kinase by 25%, 27% and 57%, urea by about 24%, 40% and 44% and creatinine by 36%, 46% and 59%. Cardiac and renal MDA fell by 26/45/40% and 19/21/3…
Extraction: extract · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.
Model: Arsenic trioxide-induced cardiotoxicity: 4 mg/kg body weight arsenic trioxide given orally for 45 days in vivo, with arsenic trioxide exposure of H9c2 cardiomyocytes in vitro
Arsenic trioxide increased tissue arsenic deposition, micronuclei frequency, creatine kinase-MB activity and lipid peroxidation, and lowered antioxidant enzyme levels. Omega-3 co-administration significantly alleviated these changes in vivo, and in vitro increased cardiomyocyte viability, reduced l…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.